Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis | Zendy

Subham Kansal | Zendy; Radhika Tandon | Zendy; Pankaj Dwivedi | Zendy; Pragya Misra | Zendy; P. R. P. Verma | Zendy; Anuradha Dube | Zendy; Prabhat Ranjan Mishra | Zendy

Open Access

Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis

Author(s) -

Subham Kansal,

Radhika Tandon,

Pankaj Dwivedi,

Pragya Misra,

P. R. P. Verma,

Anuradha Dube,

Prabhat Ranjan Mishra

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks286

Subject(s) - doxorubicin , in vivo , nanocapsules , pharmacology , phosphatidylserine , nanocarriers , drug delivery , chemistry , visceral leishmaniasis , spleen , biodistribution , drug carrier , leishmania donovani , macrophage , in vitro , immunology , leishmaniasis , biology , medicine , drug , biochemistry , chemotherapy , materials science , membrane , nanotechnology , nanoparticle , phospholipid , microbiology and biotechnology , organic chemistry

The purpose of this study was to explore the applicability, targeting potential and drug delivery to specialized phagocytes via phosphatidylserine (PS)-specific ligand-anchored nanocapsules (NCs) bearing doxorubicin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research